Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

Benzinga Newsdesk www.benzinga.com Positive 61.2%

Neg 0% Neu 0% Pos 61.2%

Canaccord Genuity analyst Whitney Ijem initiates coverage on Ocugen (NASDAQ:OCGN) with a Buy rating and announces Price Target of $12.